When applying the filters for income, 56% of the patients taking a GLP-1 had income under $40,000, thus showing that patients in lower socio-economic classes can receive the medication if clinical criteria are met
Endogenous GLP-1 alters postprandial functional connectivity between homeostatic and reward-related brain regions involved in regulation of appetite in healthy lean males: a pilot study
47,31,33,35 The relationship seems to be between pancreatitis and weight loss rather than the GLP-1 receptor agonist
Liraglutide, a human GLP-1 analogue, significantly improves beta cell function in subjects with type 2 diabetes
Abstract Neurodegenerative diseases, including Alzheimers Disease (AD) and Parkinsons Disease (PD) are common complications of diabetes, arising from insulin resistance, inflammation, and other pathological processes in the central nervous system
The clinical expression shows up in Jastreboff et al